ZMZhangfan Mao

Zhangfan Mao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhangfan Mao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Ping Dong

    Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China

    7 shared publications
  • Shaowen Zhang

    Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China

    6 shared publications
  • Haifeng Hu

    Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060 Hubei, People’s Republic of China

    4 shared publications
  • Gaoli Liu

    Department of Thoracic Surgery and Renmin Hospital of Wuhan University, Wuhan, People's Republic of China

    3 shared publications
  • Yanzhuo Liu

    Department of Pharmacology, Renmin Hospital of Wuhan University, Wuhan 430060, People’s Republic of China

    3 shared publications
  • Bo Wang

    Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China

    1 shared publication

Latest Publications

  • Open Access

    Initial experience with a novel 2-mm needle-type intracorporeal assembly forceps for periareolar video-assisted thoracoscopic surgery

    by Wei Wang, Shaowen Zhang, Ping Dong, Zhangfan Mao

    Background Periareolar video-assisted thoracoscopic surgery (VATS) provides cosmetic advantages but poses technical challenges due to limited working space. The novel 2-mm needle-type intracorporeal assembly endoscopic forceps is designed to minimize incision size while retaining full surgical functionality. This study aimed to evaluate the feasibility, safety, and effectiveness of this novel endoscopic forceps in periareolar VATS. Methods This single-center retrospective observational study included patients who underwent periareolar VATS using either the 2-mm forceps or a conventional 5-mm grasper between January and December 2024. Outcomes included operative time, complications, visual analog scale (VAS) pain scores at 1 week and 1 month, patient and observer scar assessment scale (POSAS) scores at 6 months, and surgeon feedback. Patients were stratified as follows: 2-mm group (n = 78; uniportal 45, biportal 33) and a historical 5-mm control (n = 37; all uniportal) from the same team under identical indications and perioperative protocols. Because the control contained only uniportal cases, all between-group comparisons were prespecified for the uniportal subset (2 mm: 45 vs. 5 mm: 37); 2-mm biportal cases were summarized descriptively. Results A total of 115 periareolar VATS procedures were completed without severe complications or perioperative mortality. Instrument assembly and disassembly required 100 ± 28 s and 25 ± 11 s, respectively. The needle-type puncture sites required no suturing and showed minimal-to-virtually no scarring at follow-up. In the uniportal subset, the 2-mm group had significantly lower POSAS totals and early VAS scores than the 5-mm group, with comparable operative time and surgeon-reported difficulty. Three minor mammary gland injuries occurred overall (two in the 2-mm group and one in the 5-mm group), with no lasting sensory impairment. Conclusions The novel 2-mm intracorporeal forceps is safe and effective for periareolar VATS, significantly enhancing cosmetic outcomes and surgical efficiency, suggesting broad clinical application potential.


  • Open Access

    Dual-Active Nanoimmunomodulators for the Synergistic Enhancement of the Antitumor Efficacy of Photodynamic Immunotherapy

    by Ping Dong, Shaowen Zhang, Ying Zhang, Haifeng Hu, Qing Zhou, Yanzhuo Liu, Zhangfan Mao

    Photodynamic immunotherapy, which combines photodynamic therapy (PDT) with immunotherapy, has become an important and effective treatment for cancer. However, most photodynamic immunotherapy systems for cancer do not allow for the precise release of immunomodulators, leading to systemic side effects and poor patient prognosis. This study reports a dual-activatable nanoimmunomodulator (CPPM), whose photodynamic effect and agonist release are both activated in response to specific stimuli, which can be used for precise photodynamic immunotherapy of cancer. CPPM has a half-life of 119 min in circulation and accumulates in tumor tissue 4 h after injection (23.8%). In addition, CPPM is able to achieve tumor localization of nanomedicines through PD-L1-targeting peptides, blocking the specific binding of PD-L1 to PD-1, exposing tumor surface antigens, and reinvigorating the activity of T cells in combination with macitentan to promote T-cell proliferation. Meanwhile, under laser irradiation, CPPM was able to increase intracellular oxidative stress, inhibit cell proliferation through PDT, and trigger immunogenic cell death, further enhancing tumor immunogenicity through synergistic treatment. Ultimately, CPPM enhanced the immunotherapeutic efficiency against tumors by improving the tumor immunosuppressive microenvironment, synergistically inhibiting the growth of primary and distant tumors while activating systemic antitumor immunity to eliminate lung metastases without obvious side effects. This study presents an uncomplicated and multifunctional strategy for the precise modulation of tumor photodynamic immunotherapy with a dual-activatable smart nanoimmunomodulator that can improve the efficacy of PDT, enhance systemic antitumor immunity, and potentially extend it to a wide range of cancers.


  • Transareolar Video-Assisted Thoracoscopic Surgery in Females: A Novel Incision for Pulmonary Ground Glass Nodule Resection

    by Yanzhuo Liu, Ping Dong, Shaowen Zhang, Qing Geng, Zhangfan Mao

    Purpose: Uniportal video-assisted thoracoscopic surgery (VATS) is recognized for its minimally invasive nature, widely adopted globally. However, the evident scarring it leaves often triggers psychological apprehension and resistance to surgery. Transareolar incision, known for its superior cosmetic outcome with no visible scars, poses challenges in women due to the risk of mammary gland damage. In this report, we present successful pulmonary ground glass nodule (GGN) resection using transareolar VATS in female patients, aiming to address these concerns. Materials and Methods: We retrospectively analyzed the clinical data of 35 female patients who underwent GGN resection through transareolar VATS between August 2020 and March 2022. Results: There were no serious complications or perioperative deaths in this cohort of 35 female patients undergoing GGN resection through transareolar VATS. The operations, including local resection or segmentectomy, had an average duration of 70.1 ± 26.4 minutes, with a tube duration of 4.7 ± 2.1 days and a hospitalization time of 7.2 ± 2.3 days. The surgical approach varied, with 21 cases using transareolar uniport, 8 cases assisted by a 3-mm tiny port, and 6 cases converted to two-port VATS. Scar outcomes varied, with 21 cases showing no scar, 8 cases displaying a microscar, and 6 cases presenting a dominant scar of 1.7 ± 0.5 cm. Postoperative pain scores at 1 week and 1 month were 1.9 ± 0.9 and 1.0 ± 0.9, respectively, and the wound numbness occurred in 2.86% (1/35) of cases. Regarding breast complications, 2 patients suffered delayed healing of the incision. No damage and inflammation of glands were detected by breast B-mode ultrasonography. Conclusions: The transareolar incision emerges as a novel approach for VATS in female patients, offering advantages in terms of pain management and cosmetic outcomes.


  • Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing

    by Shaowen Zhang, Ping Dong, Zongwei Pan, Qian Chen, Junqi Zhu, Zhangfan Mao

    Background Disease prognosis after resection of lung cancer could be affected by pathological subtypes. In this study, we investigated the difference of gene variation and significantly altered pathways between adenocarcinoma in situ (AIS)/microinvasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) subtypes to reveal the molecular mechanism of prognosis differences. Methods Sixty one tumor tissues were subjected to DNA extraction and customized 136 gene targeted next-generation sequencing. Comparisons between groups were performed with two-sided Fisher’s exact test for categorical variables and two-tailed unpaired t test for numerical variables. Results A total of 402 somatic mutations involved in 70 genes were detected in all these samples, and 74.29% of these genes were mutated in at least two samples. PMS2, ARID1A, EGFR, and POLE were the most frequently mutated genes. ALK_EML4 fusion was observed in one IAC patient and RET_ KIF5B fusion in one AIS patient. A significant higher proportion of patients with TP53 gene mutation was observed in the IAC group (P = 0.0057). The average onset age in IAC group is 62.48 years, which is greater than other subtypes (P = 0.0166). It revealed that mutations in genes involved in the mTOR signaling pathway (56.52% vs 26.32%, P = 0.0288) and Hippo signaling pathway (34.78% vs 10.53%, P = 0.0427) were significantly enriched in IAC subtypes, suggesting the key involvement of mTOR and Hippo signaling pathways in lung tumor development and malignant progression. Conclusions This study revealed the heterogeneity of gene mutations and significantly altered pathways between different lung cancer subtypes, suggesting the potential mechanism of different prognosis.


  • Two-Centimeter Single-Port Incision Minimizing Intercostal Nerve Damage Applied in Video-Assisted Thoracoscopic Surgery Segmentectomy for Pulmonary Ground Glass Nodules

    by Haifeng Hu, Yanzhuo Liu, Ping Dong, Shaowen Zhang, Gaoli Liu, Zhangfan Mao

    Purposes: We introduced a novel modified 2-cm single-port incision made by blunt separation minimizing intercostal muscle and nerve damage applied in video-assisted thoracoscopic surgery (VATS) segmentectomy, and compared it with the traditional single-port incision or the novel incision plus a 3-mm tiny port, aiming to explore a more minimally invasive single-port technique for VATS segmentectomy. Materials and Methods: We retrospectively analyzed the clinical data of 174 pulmonary ground glass nodule patients who received single-port VATS segmentectomy (54 modified 2-cm single port, 67 modified single port plus tiny port, and 53 traditional single port, respectively) in our medical center from May 2020 to December 2022. Three kinds of approaches were compared retrospectively, concerning their safety, feasibility, and postoperative pain. Results: There were no serious complications and mortality in either group. The blood loss, tube duration, and hospitalization time were comparable among the three groups ( P > .05). The 2-cm single-port and 2-cm single-port plus tiny-port group were obviously more advantageous in the visual analog scores of postoperative pain, the wound numbness, incision healing and appearance than that in the traditional group ( P < .05), while they were comparable. Notably, the operation time of the 2-cm plus tiny-port group was shorter than that of the 2-cm group ( P < .05) and similar to the traditional single-port group. Conclusions: The 2-cm modified single-port applied for VATS segmentectomy is feasible and safe, and has obviously advantages in postoperative pain, numbness, and appearance of incision. With addition of tiny port, the convenience of the operation can be significantly increased without increasing pain. Our finding could provide a promising new incision mode for VATS segmentectomy.


  • Modified 2-cm super single port vs. the traditional 3-cm single port for video-assisted thoracoscopic surgery lobectomy

    by Gaoli Liu, Ping Dong, Haifeng Hu, Shaowen Zhang, Zhangfan Mao

    Purposes We introduce a novel 2-cm single port designed to minimize intercostal muscle and nerve damage in video-assisted thoracoscopic surgery (VATS) lobectomy, and compared it with the 3-cm traditional single port. Methods We analyzed, retrospectively, the clinical data, safety, convenience, incision complications, and postoperative pain and numbness in 81 patients who underwent either modified (n = 42) or traditional (n = 39) single-port VATS lobectomy. Results The preoperative variables were comparable between both single-port VATS lobectomy groups after matching. There were no serious complications and there was no mortality in either group. There were no remarkable differences between the groups in intraoperative blood loss, chest tube duration, lymph node dissection, or postoperative complications. The modified single-port group had a longer operation time (p < 0.05), but the static and dynamic postoperative VAS scores and incisional numbness were better in the modified single-port group (p < 0.05). The modified single-port group also had an obvious advantage in incision seepage, healing, and appearance. Conclusions Our 2-cm modified single port for lobectomy is safe and effective, and results in less postoperative pain and incisional numbness than the 3-cm traditional single port.


  • Modified left subsuperior segmentectomy via 2-cm uniportal video-assisted thoracoscopic surgery

    by Gaoli Liu, Haifeng Hu, Ping Dong, Shaowen Zhang, Zhangfan Mao

    Independent subsuperior segmentectomy (S*) via uniportal video-assisted thoracoscopic surgery (VATS) has rarely been reported. We describe our modified technique of performing simplified left subsuperior segmentectomy for a lung nodule, via 2-cm uniportal VATS. The uniportal approach was different from the traditional approach made by blunt separation into the thorax without electrocautery. Our modified technique minimizes damage to the intercostal nerves and muscles. We also simplified the subsuperior segmentectomy procedure according to the findings of three-dimensional (3D) computed tomography angiography and bronchography. Combining these two techniques achieves a new more minimally invasive method for subsuperior segmentectomy.